Fate Therapeutics, Inc. (FATE)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 11:39AM EDT. Market open.
| Previous Close | 4.0600 |
| Open | 4.0800 |
| Bid | 3.0000 x 200 |
| Ask | 5.1900 x 200 |
| Day's Range | 4.0100 - 4.1600 |
| 52 Week Range | 1.6300 - 8.8300 |
| Volume | |
| Avg. Volume | 2,624,651 |
| Market Cap | 469.495M |
| Beta (5Y Monthly) | 1.68 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Fate Therapeutics (FATE) Surges 86.4% YTD on Pipeline Progress
Fate Therapeutics (FATE) gains 86.4% on encouraging pipeline progress of its cellular immunotherapies for cancer.
- Zacks
Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report?
Amicus Therapeutics (FOLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Why Is Myriad (MYGN) Down 1% Since Last Earnings Report?
Myriad (MYGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2024 Yahoo. All rights reserved.